(Q38261159)

1 September 2017

1 reference

title

Exercise in muscle glycogen storage diseases (English)

1 reference

glycogen metabolic process

1 September 2017

main subject

1 reference

Nicolai Preisler

1

1 reference

1 September 2017

Ronald G Haller

series ordinal

2

1 reference

1 September 2017

John Vissing

series ordinal

3

1 reference

1 September 2017

publication date

18 October 2014

1 reference

Journal of Inherited Metabolic Disease

1 September 2017

published in

1 reference

1 September 2017

volume

38

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

551-563

1 reference

https://scigraph.springernature.com/pub.10.1007/s10545-014-9771-y

1 September 2017

exact match

0 references

cites work

2011 Compendium of Physical Activities: a second update of codes and MET values

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Effect of oral sucrose shortly before exercise on work capacity in McArdle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Limiting factors for maximum oxygen uptake and determinants of endurance performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Diagnosis of glycogenosis type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Debrancher deficiency: Neuromuscular disorder in 5 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Human Muscle Phosphoglycerate Mutase Deficiency: Newly Discovered Metabolic Myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Muscle phosphorylase b kinase deficiency revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

No spontaneous second wind in muscle phosphofructokinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Aerobic conditioning: an effective therapy in McArdle's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

A non-ischemic forearm exercise test for the screening of patients with exercise intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

A nonischemic forearm exercise test for McArdle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Glycogen storage disease type III diagnosis and management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

McArdle disease: what do neurologists need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Exercise testing in late-onset glycogen storage disease type II patients undergoing enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Neuromuscular involvement in glycogen storage disease type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Permanent muscle weakness in McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Muscle phosphoglycerate mutase deficiency revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Phosphofructokinase deficiency; past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Exercise-induced cramp, myoglobinuria, and tubular aggregates in phosphoglycerate mutase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Fat metabolism during exercise in patients with McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

A metabolic myopathy due to absence of muscle phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Evidence for prescribing exercise as therapy in chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Physical training for McArdle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Exercise, GLUT4, and skeletal muscle glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

American College of Sports Medicine position stand. Nutrition and athletic performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Multiple phenotypes in phosphoglucomutase 1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

A randomized study of alglucosidase alfa in late-onset Pompe's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

The effects of increasing exercise intensity on muscle fuel utilisation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

The effect of oral sucrose on exercise tolerance in patients with McArdle's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Muscle glycogenosis due to phosphoglucomutase 1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9771-Y

Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency

21 January 2018

1 reference

12 December 2020

Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy

1 reference

12 December 2020

Table of nonprotein respiratory quotient: an update

1 reference

12 December 2020

Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VII

1 reference

12 December 2020

The relative activities attributable to the three phosphoglucomutase loci (PGM1, PGM,2PGM3) in human tissues

1 reference

12 December 2020

Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.

1 reference

12 December 2020

Favorable responses to acute and chronic exercise in McArdle patients

1 reference

12 December 2020

Regulation of glycogenolysis in human muscle at rest and during exercise

1 reference

12 December 2020

The ischemic exercise test in normal adults and in patients with weakness and cramps

1 reference

12 December 2020

Strength training and aerobic exercise training for muscle disease

1 reference

12 December 2020

Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy

1 reference

12 December 2020

Myophosphorylase deficiency impairs muscle oxidative metabolism

1 reference

12 December 2020

Exercise tolerance and daily life in McArdle's disease

1 reference

12 December 2020

Exercise intolerance in Glycogen Storage Disease Type III: Weakness or energy deficiency?

1 reference

12 December 2020

Muscle phosphorylase kinase deficiency: A neutral metabolic variant or a disease?

1 reference

12 December 2020

Isolation of a cDNA encoding the B isozyme of human phosphoglycerate mutase (PGAM) and characterization of the PGAM gene family.

1 reference

12 December 2020

Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase.

1 reference

12 December 2020

Myopathy and phosphorylase kinase deficiency caused by a mutation in thePHKA1 gene

1 reference

12 December 2020

Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease

1 reference

12 December 2020

Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy

1 reference

12 December 2020

Muscle Glycogen during Prolonged Severe Exercise

1 reference

12 December 2020

Fat and carbohydrate metabolism during exercise in late-onset Pompe disease

1 reference

12 December 2020

Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men

1 reference

12 December 2020

Metabolic consequences of muscle disuse atrophy

1 reference

12 December 2020

The Subgroups of Type III Glycogenosis

1 reference

12 December 2020

10.1007/S10545-014-9771-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1030020923

0 references

1 reference